Corporate Profile

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California.

Recent Press Releases

July 26, 2017 - 4:04 p.m.
Gilead Sciences Announces Third Quarter 2017 DividendPrinter Friendly Version 
July 26, 2017 - 4:02 p.m.
Gilead Sciences Announces Second Quarter 2017 Financial ResultsPrinter Friendly Version 

Upcoming Events

Sunday, July 23, 2017 through Wednesday, July 26, 2017
9th IAS Conference on HIV Science
LocationParis, France

Most Viewed Links

Updated 07/26/17
1.SEC Filings
3.Annual Reports
4.U.S. Food and Drug Administration Approves Gilead’s Vosevi™ (Sofosbuvir/Velpatasvir/Voxilaprevir) for Re-Treatment of Adults with Chronic Hepatitis C Virus
5.Stock Information
* Data collected 07/18/17 - 07/25/17

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
NASDAQ (US Dollar)
 Stock is Up 0.45 (0.61%)
Data as of 07/26/17 4:00 p.m. ET
Minimum 20 minute delay
Refresh Quote
Recent Webcasts
Goldman Sachs 38th Annual Global Healthcare Conference

June 15, 2017 10:00 a.m. PT
37th Annual William Blair Growth Stock Conference

June 13, 2017 10:10 a.m. CT